Use of prescribed and non-prescribed medicines by the elderly: Implications for who chooses, who pays and who monitors the risks of medicines

International Journal of Pharmacy Practice

Volumn 13, Issue 2, 2005, Pages 133-140

  Ballantyne, Peri J ^a,c   Clarke, Philippa J ^b   Marshman, Joan A ^c   Victor, J Charles ^c   Fisher, Judith E ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ASCORBIC ACID; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM SALT; CAPTOPRIL; COCODAMOL; DICLOFENAC; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ECHINACEA EXTRACT; FAMOTIDINE; FUROSEMIDE; GARLIC EXTRACT; GINSENG EXTRACT; GLUCOSAMINE; GLYCERYL TRINITRATE; HYDROCHLOROTHIAZIDE; HYDROCORTISONE; INSULIN; LEVOTHYROXINE; LISINOPRIL; MINERAL; MULTIVITAMIN; N05ZZ99; NATURAL PRODUCT; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PIROXICAM; PROPRANOLOL; RANITIDINE; SEDATIVE AGENT; UBIDECARENONE; UNCLASSIFIED DRUG; VERAPAMIL;

AEROSOL; AGED; CANADA; COMMUNITY CARE; CREAM; DRUG CHOICE; DRUG USE; FEMALE; HEALTH CARE ACCESS; HEALTH STATUS; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PHARMACIST; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK; SELF REPORT; TABLET;

EID: 20444402670     PISSN: 09617671     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357056217     Document Type: Review

References (34)

1. Commission on the Future of Health Care in Canada. Building on values. The future of health care in Canada. 2002. Final Report, www.hc-sc.gc.ca/ english/care/romanow/ (accessed March 3, 2005).
2. O'Neill C, Hughes CM, Jamison J, Schweizer A. Cost of pharmacological care of the elderly - implications for healthcare resources. Drugs Aging 2003;20:253-61.
3. Anderson G, Petrosyan V, Hussey PS. Multinational Comparisons of Health Systems Data, 2002. New York: Commonwealth Fund, Publication No. 582; October 2002. www.cmwf.org/usr_doc/anderson_multinational-comparisions2002_582.pdf (accessed March 7, 2005).
4. Health care in Canada. Ottawa, ON: Canadian Institute for Health Information; 2002.
5. Drug expenditure in Canada 1985-2002. Ottawa, ON: Canadian Institute for Health Information; 2003. http:// www.cihi.ca (accessed March 3, 2005).
6. Shah ND, Hoffman JM, Vermeulen LC, Hunkle, RJ, Hontz KM. Projecting future drug expenditures - 2003. Am J Health Syst Pharm 2003;60:137-49.
7. Lexchin J. After compulsory licensing: coming issues in Canadian pharmaceutical policy and politics. Health Policy 1997;40:69-80.
8. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States. The Slone Survey. JAMA 2002;287:337-44.
9. Linjakump T, Hartikainen S, Klaukka T, Veijola J, Kivela S, Isoaho R. Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol 2002;55:809-17.
10. Chen YF, Dewey ME, Avery AJ and the Analysis Group of the MRCCFA Study. Self-reported medication use for older people in England and Wales. J Clin Pharm Ther 2001; 26:129-40.
11. Barat I, Andreasen F, Damsgaard EMS. The consumption of drugs by 75-year-old individuals living in their own homes. Eur J Clin Pharmacol 2000;56:501-9.
12. Thomas HF, Sweetnam PM, Janchawee B, Luscombe DK. Polypharmacy among older men in South Wales. Eur J Clin Pharmacol 1999;55:411-15.
13. Roe CM, McNamara AM, Motheral BR. Use of chronic medications among a large, commercially-insured US population. Pharmacoepid Drug Safety 2002;11:301-9.
14. Al-Windi A, Elmfeldt D, Svärdsudd K. The relationship between age, gender, well-being and symptoms, and the use of pharmaceuticals, herbal medicines and self-care products in a Swedish municipality. Eur J Clin Pharmacol 2000;56:311-17.
15. Bjerrum L, Søgaard J, Hallas J, Kragstrup J. Polypharmacy: correlations with sex, age and drug regimen. A prescription database study. Eur J Clin Pharmacol 1998;54:197-202.
16. Chrischilles EA, Foley DJ, Wallace RB, Lemke JH, Semla TP, Hanlon JT, et al. Use of medications by persons 65 and over: data from the Established Populations for Epidemiologic Studies of the Elderly. J Gerontol Med Sci 1992;47: M137-M144.
17. Raulose-Ram R, Hirsch R, Dillon C, Losonczy K, Cooper M, Ostchega Y. Prescription and non-prescription analgesic use among the US adult population: results from the third National Health and Nutrition Examination Survey (NHANES III). Pharmacoepid Drug Safety 2003;12:315-26.
18. Mount JK. Quantity and appropriateness of non-prescribed drug use in a high risk elderly population: prevalence and correlates. J Soc Admin Pharm 1991;8:25-32.
19. Rantucci M, Segal HJ. Hazardous non-prescription analgesic use by the elderly. J Soc Admin Pharm 1991;8:108-20.
20. McKenzie J, Keller H. Vitamin-mineral supplementation and use of herbal preparations among community-living older adults. Can J Pub Health 2001;92:286-9.
21. Swain L, Catlin G, Beaudet M. The National Population Health Survey-its longitudinal nature. Health Rep 1999;10:69-81.
22. Statistics Canada. A national overview - population and dwelling counts (data products: 1996 census of population). Catalogue No: 93-357-XPB. www.statcan.ca/english/ census96/table15.htm (accessed March 3, 2005).
23. Tambay JL, Catlin G. Sample design of the National Population Health Survey. Health Rep 1995;7:1-11.
24. Ballantyne PJ, Hawker GA, Radoeva D. Social-psychological and structural factors influencing the experience of chronic disease: a focus on individuals with severe arthritis. Social and Economic Dimensions of an Aging Population (SEDAP) Working Paper Series Research Paper No. 38. http://socserv2.mcmaster.ca/ sedap (accessed March 3, 2005).
25. Lumme-Sandt K, Virtanen P. Older people in the field of medication. Soc Health Illness 2002;24:285-304.
26. Wolinsky FD, Arnold CL. A different perspective on health and health services utilization. Ann Rev Gerontol Geriatr 1998;8:71-101.
27. Wolinsky FD, Culler SD, Callahan CM, Johnson RJ. Hospital resource consumption among older adults: a prospective analysis of episodes, length of stay, and charges over a seven-year period. J Gerontol Psychol Sci Soc Sci 1994;49:S240-52.
28. Verbrugge LM. Gender and health: an update on hypothesis and evidence. J Health Soc Behav 1985;26:156-82.
29. Ontario College of Pharmacists. Changes to the Ontario Drug Benefit program. Pharmacy Connection 1996;3: 22-3.
30. Hux J, Fielding D. The Ontario Drug Benefit Program co-payment: its impact on access for Ontario seniors and charges to the program. Toronto: Institute for Clinical Evaluative Sciences in Ontario Working Paper; 1997.
31. Harten C, Ballantyne P. Impact of cost-sharing within provincial drug benefit programs: a review. J Pharm Finance Econ Policy 2004;13:35-53.
32. Lexchin, J, Grootendorst P. Effects of prescription drug user fees on drug and health services use and on health status in vulnerable populations: a systematic review of the evidence. Int J Health Serv 2004;34: 101-22.
33. Haug MR, Wykle ML, Namaz KH. Self care among older adults. Soc Sci Med 1989;29:171-83.
34. Wilkinson IF, Darby DN, Mant A. Self-care and self-medication: an evaluation of individuals' health care decisions. Med Care 1987;25:965-78.